Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Localized Prostate Carcinoma: early-phase trial registry
10 of 15 indexed Localized Prostate Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 10 currently recruiting · #1,140 of 28,707 conditions by registered trial count
Localized Prostate Carcinoma: 15 US clinical trials tracked, 10 recruiting.
Localized Prostate Carcinoma is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 3 of these trials.
Enrollment posture brief
Registry condition localized-prostate-carcinoma
OPEN 10 | RECR 67% | LATE 0 | EARLY 9 | RANK #1140 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Localized Prostate Carcinoma lists 10 open slots (67% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Localized Prostate Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Localized Prostate Carcinoma is recruiting above its size-band peers.
10 of 15 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Localized Prostate Carcinoma research.
Mayo Clinic accounts for 3 of 15 trials (20%). 12 distinct sponsors appear on at least one study for this condition label.
-
Most Localized Prostate Carcinoma trials plan to enrol fewer than 100 people.
Median target enrolment is 45 among the 15 trials that report a genuine target (sentinel values excluded). 12 of those (80%) plan for fewer than 100 participants.
-
Localized Prostate Carcinoma research is mostly interventional.
15 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
Mayo Clinic
NCT05045066
Addressing Health Literacy With a Tailored Survivorship Care Plan
Emory University
NCT06674863
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
Marc Dall'Era, MD
NCT06178354
Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer
Ivan de Kouchkovsky, MD
NCT02526368
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
City of Hope Medical Center
NCT05722288
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
Mayo Clinic
NCT06389786
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Thomas Hope
NCT07054346
Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy
Mayo Clinic
NCT06940271
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
University of Southern California
NCT06500169
Two-fraction HDR Monotherapy for Localized Prostate Cancer
University of California, San Francisco
NCT05665738
RElugolix VErsus LeUprolide Cardiac Trial
Emory University
NCT05320406
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Memorial Sloan Kettering Cancer Center
NCT05751434
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
National Cancer Institute (NCI)
NCT04530552
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer
Robert Flavell, MD, PhD
NCT05851365
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer
M.D. Anderson Cancer Center
NCT04978675
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Localized Prostate Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Localized Prostate Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Localized Prostate Carcinoma page
15 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Localized Prostate Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mayo Clinic sponsors the most Localized Prostate Carcinoma trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Localized Prostate Carcinoma condition card totals 15 registered trials; most-linked intervention Biospecimen Collection; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.